Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 46Neoplasms 32Lung Neoplasms 25Colorectal Neoplasms 22Uterine Cervical Neoplasms 14Prostatic Neoplasms 13Motor Activity 11Colonic Neoplasms 10Anxiety Disorders 9Rectal Neoplasms 8Pancreatic Neoplasms 8Obesity 8Carcinoma, Non-Small-Cell Lung 8Hematologic Neoplasms 7Endometrial Neoplasms 7Depression 7Ovarian Neoplasms 6Lymphoma 6Breast Carcinoma In Situ 6Vulvar Neoplasms 5Urinary Bladder Neoplasms 5Neoplasm Metastasis 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4Smoking Cessation 4Pain 4Melanoma 4Leukemia, Myeloid, Acute 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Neoplasms 4

Interventions

Resistance Training 3Nutritional Status 2Resistant Starch 1Plant Proteins 1Nutrition Assessment 1Methods 1Exercise Movement Techniques 1Exercise 1Ethanol 1Endodontics 1Educational Status 1Early Intervention, Educational 1Diet 1Continuous Glucose Monitoring 1Circuit-Based Exercise 1Cholecalciferol 1Blood Specimen Collection 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Diabetes Mellitus, Type 2 × Methods × Clear all
NCT04938869 2023-02-24

Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
3 enrolled

Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡